Literature DB >> 22024796

The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.

Jamie P Nourse1, Rod Lea, Pauline Crooks, Gillian Wright, Huyen Tran, John Catalano, Tim Brighton, Andrew Grigg, Paula Marlton, Maher K Gandhi.   

Abstract

Adult immune thrombocytopenia (ITP) is a heterogeneous disease and its immunobiology is incompletely understood. Establishing associations between candidate genes and ITP susceptibility may provide insight into pathogenesis. Previous studies have associated overrepresentation of FCGR3a-V158 allele with pediatric ITP. We prospectively accrued DNA from 102 adult patients with persistent/chronic or relapsed primary ITP identified by defined criteria. The distribution of KIR2 genes and polymorphisms of FCGR3a, both associated with autoimmunity, were compared with 105 healthy white individuals. Results were stratified by ethnicity. Carriers of the KIR2DS2/KIR2DL2 genotype [KIR2DS2/KIR2DL2 versus KIR2DS2/KIR2DL2 and KIR2DS2/KIR2DL2; odds ratio (OR) 2.51, P = 0.002] were overrepresented. In addition, frequency of the high-binding affinity FCGR3a-V/V158 genotype (VV versus VF/FF; OR = 3.05, P = 0.007) was increased, whereas that of the FCGR3a-F158 allele was reduced (OR = 2.58, P = 0.00.002). In a regression model to adjust for age, sex and the effects of the other gene, the KIR2 genotype independently conferred increased susceptibility from the FCGR3a-158 polymorphisms. In a comparison of healthy controls and a tightly defined cohort of adult ITP patients, the KIR2DS2/KIR2DL2 genotype was found to be associated with ITP independently of FCGR3a-158 polymorphisms. Further studies are required to establish the mechanistic basis for these observations and their potential impact on immune-based therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22024796     DOI: 10.1097/MBC.0b013e32834d7ce3

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

Review 1.  Missing or altered self: human NK cell receptors that recognize HLA-C.

Authors:  Hugo G Hilton; Peter Parham
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

2.  KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.

Authors:  A Rivero-Juarez; R Gonzalez; M Frias; B Manzanares-Martín; D Rodriguez-Cano; I Perez-Camacho; A Gordon; F Cuenca; A Camacho; J A Pineda; J Peña; A Rivero
Journal:  Pharmacogenomics J       Date:  2016-03-15       Impact factor: 3.550

Review 3.  CD16 and CD32 Gene Polymorphisms May Contribute to Risk of Idiopathic Thrombocytopenic Purpura.

Authors:  Jiannan Xu; Liyun Zhao; Yan Zhang; Qingxu Guo; Hui Chen
Journal:  Med Sci Monit       Date:  2016-06-18

4.  The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.

Authors:  Kristy Purnamawati; Jamie Ann-Hui Ong; Siddharth Deshpande; Warren Kok-Yong Tan; Nihar Masurkar; Jackson Kwee Low; Chester Lee Drum
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

5.  Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.

Authors:  Heiner Zimmermann; Theresa Weiland; Jamie P Nourse; Maher K Gandhi; Petra Reinke; Ruth Neuhaus; Mohsen Karbasiyan; Barbara Gärtner; Ioannis Anagnostopoulos; Hanno Riess; Ralf U Trappe; Stephan Oertel
Journal:  J Immunol Res       Date:  2014-02-10       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.